GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

REWIND in The Lancet and ADA 2019

Dr. Hertzel Gerstein, PI, REWIND

Simultaneous publication by The Lancet journal – in two [full text] articles, one on renal outcomes, the other on CV outcomes as they relate to the REWIND trial – and presentation of the trial’s findings by Dr. Hertzel Gerstein at the American Diabetes Association (ADA) Scientific Sessions in San Francisco happened on June 9, 2019. 

Visit phri.ca/REWIND to download Dr. Gerstein’s presentation slides [ppt]. The same location contains links to the two Lancet articles, and three earlier publications about REWIND.